Key Details
Price
$17.01Annual Revenue
$16.03 MAnnual EPS
-$3.42Annual ROE
-153.57%Beta
-0.11Events Calendar
Next earnings date:
Mar 13, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 13, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 15, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
electroCore's gammaCore, an FDA-approved nVNS device, generates recurring revenue and has significant expansion potential within the VA system and other healthcare channels. The company is diversifying with the rugged TAC-STIM for military use and the consumer-focused Truvaga Plus, targeting wellness markets. The recent acquisition of NeuroMetrix's Quell system for fibromyalgia offers revenue and cost synergies, leveraging electroCore's established sales channels.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) provided investors with a general update on its royalty and stream portfolio projects, as well as news that the company will join the FTSE UK SmallCap Index and the FTSE UK All-Share Index, effective 23 December 2024. Of its three producing royalties, the company recalled that Vale Base Metals has completed the Voisey's Bay mine expansion project, transitioning operations from open pit to underground mining.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has noted yesterday's confirmation from operator Vale that it had completed the Voisey's Bay Mine Expansion Project. Royalty specialist Ecora has a stream agreement which entitles it to 22.82% of all cobalt production from the Voisey's Bay mine up to 7,600t of finished cobalt, after which the percentage drops to 11.41%.
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.68 per share a year ago.
electroCore (ECOR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ROCKAWAY, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Thomas Freeburg will join electroCore, effective November 11, 2024, as the Company's VP, Corporate Controller. The Compensation Committee of electroCore's Board of Directors granted 5,000 restricted stock units (“RSUs”) to Mr. Freeburg in connection with the commencement of his employment. The RSUs were granted as an inducement material to Mr. Freeburg's commencement of employment pursuant to NASDAQ Listing Rule 5635(c)(4). 33% of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to Mr. Freeburg's continued employment by the Company on the applicable vesting date. Upon vesting, the RSUs shall be settled in shares of the Company's common stock.
Ecora Resources PLC's (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) comments regarding the Voisey's Bay cobalt operation stream were the most significant component of its third quarter update, according to Peel Hunt. The four deliveries in the quarter matched the total deliveries for all of 2023, notes the broker.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) portfolio income dropped by 10% in its latest quarter as the contribution from its coking coal royalty at Kestrel fell sharply as expected. Without Kestrel, where mining shifted to areas outside of Ecora's royalty, income in the three months to end September 2024 rose by 4% to US$5 million helped by an almost tripled contribution from the cobalt operation at Voisey Bay.
electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Rockaway, New Jersey--(Newsfile Corp. - October 14, 2024) - electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the LD Micro Main Event XVII on Tuesday, October 29 at 4:30 p.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
FAQ
- What is the primary business of electroCore?
- What is the ticker symbol for electroCore?
- Does electroCore pay dividends?
- What sector is electroCore in?
- What industry is electroCore in?
- What country is electroCore based in?
- When did electroCore go public?
- Is electroCore in the S&P 500?
- Is electroCore in the NASDAQ 100?
- Is electroCore in the Dow Jones?
- When was electroCore's last earnings report?
- When does electroCore report earnings?
- Should I buy electroCore stock now?